SEC Form 4 · accession 0001078782-18-000415
AXIM BIOTECHNOLOGIES, INC. · AXIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Malasek
Officer — CFO
Period of report
Mar 21, 2018
Accepted (ET)
Apr 6, 2018 · 3:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001514946
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2018 | A | 50,000 | $0.00 | A | 50,000 | D |
Table II — derivative securities
No Table II lines on this filing.